BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18160071)

  • 1. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.
    Harris WS; Miller M; Tighe AP; Davidson MH; Schaefer EJ
    Atherosclerosis; 2008 Mar; 197(1):12-24. PubMed ID: 18160071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hypertriglyceridemia with omega-3 fatty acids].
    Miyoshi T; Ito H
    Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine lipids: overview "news insights and lipid composition of Lyprinol".
    Sinclair AJ; Murphy KJ; Li D
    Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
    Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary omega-3 fatty acids for women.
    Bourre JM
    Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids from fish oils and cardiovascular disease.
    Holub DJ; Holub BJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
    Kar S
    Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.
    Harper CR; Jacobson TA
    Am J Cardiol; 2005 Dec; 96(11):1521-9. PubMed ID: 16310434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary n-6 and n-3 fatty acid balance and cardiovascular health.
    Wijendran V; Hayes KC
    Annu Rev Nutr; 2004; 24():597-615. PubMed ID: 15189133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids for cardioprotection.
    Lee JH; O'Keefe JH; Lavie CJ; Marchioli R; Harris WS
    Mayo Clin Proc; 2008 Mar; 83(3):324-32. PubMed ID: 18316000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
    Harris WS; Dayspring TD; Moran TJ
    Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding omega-3 polyunsaturated fatty acids.
    Calder PC; Yaqoob P
    Postgrad Med; 2009 Nov; 121(6):148-57. PubMed ID: 19940425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.